World Rare Disease Day: GEXVal Presents Posters at 5th Tsukuba Co-creation Conference
2026年3月3日
株式會社GEXValMarch 3, 2026 World Rare Disease Day: GEXVal Presents Two Posters at 5th Tsukuba Co-creation Confere […]
Rare Disease Day Update: FRAXA Features GEXVal’s FRAXA-DVI Completion and FDA Orphan Drug Designation
2026年2月28日
株式會社GEXValFebruary 28, 2026 FRAXA Research Foundation Features GEXVal's Completion of FRAXA-DVI Program and FD […]
GEXVal Selected as Presenting Company at Biotech Showcase™ 2026
2026年1月7日
株式會社GEXValJanuary 7, 2026 GEXVal Selected as Presenting Company at Biotech Showcase™ 2026 GEXVal Inc. (Preside […]
GEXVal Featured in BioCentury Article
2025年12月22日
株式會社GEXValDecember 22, 2025 GEXVal Featured in BioCentury Article “Raising the Sun: Japan Biotech Looks to Lev […]
GEXVal Senior Director Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025年12月12日
株式會社GEXValDecember 12, 2025 GEXVal Senior Director Delivers Lecture at University of Tokyo Hospital TR/Academi […]

